Aksys set to launch daily haemodialysis home system
This article was originally published in Clinica
Executive Summary
We don't treat high blood pressure three times a week, why do we dialyse people three times a week? We don't let diabetes go untreated for two or three days, yet we let end-stage renal disease (ESRD) patients go two or three days without treatment." Speaking at the US Bancorp Piper Jaffray healthcare conference in New York last month, William Dow, president and CEO of Aksys, outlined the case for more frequent dialysis, referring to his company's personal haemodialysis system (PHD) designed to offer daily treatment in the home.